Search results for: 'pace solar cell'

As cell and gene therapy (CGT) moves from ultra-rare indications to more common indications, manufacturing capabilities will have to expand to support the commercial requirements of these diseases. Contract research organizations (CROs) can play a critical role in long-term genetic analysis and monitor safety and efficacy up to 15 years after treat...

Battery energy storage systems (BESS) have rapidly become the fastest-growing clean energy technology driven by the growth of wind and solar and the need for grid flexibility. While commercial and industrial (C&I) BESS installations have traditionally lagged behind grid-scale and residential deployments, the sector holds considerable opportunit...

This study explores the global immuno-oncology (I-O) markets evolution from 2020 to 2025. An extensive analysis is provided on the growth opportunities envisioned by Frost & Sullivan to help stakeholders leverage their momentum and disrupt the market by offering best-in-class solutions. The study considers oncology agents for which the immune syst...

This Frost Radar analysis examines the companies and technologies advancing early weather warning for solar and wind assets. As renewable capacity expands, extreme weather, rapid changes in wind and irradiance, and limited response time increasingly affect generation, equipment integrity, and operating costs. The analysis assesses companies using F...

The connected era and cloud-based environment have created a need to redesign network operations. In addition, businesses find it operationally draining to utilize resources on ensuring a connected ecosystem rather than focusing on critical business issues. Software-defined Wide Area Network (SD-WAN) helps enterprises build an agile and automated e...

05 Aug 2024  |  Global  |  Technology Research

CGT Research Outlook and Technology Growth Opportunities

CGT Landscape Assessment

Infographics

×

The CGT landscape has evolved extensively over the past decade. More than 80 CGT products have been commercialized globally, with 34 FDA-approved cell and gene therapies in 2023 alone. The rise in product pipelines and clinical success rates has led to the growing demand for the development of new technology platforms, manufacturing capabilities, a...

There are numerous companies developing immunotherapy approaches to treat cancer, autoimmune and several other diseases. Current study describes some of the recent advances in immunotherapy, mostly cancer. These include refined cell therapies, stem cell applications in cancer treatment, monoclonal, polyclonal and bispecific antibodies. Some of exci...

Worldwide cancer incidence is expected to exceed 35 million new cases by 2050, a 77% rise from the 20 million cases in 2022. Alcohol intake, tobacco usage, obesity, and air pollution are the main causes of this increase. Cancer studies today emphasize cell and gene therapy, antibody-drug conjugates (ADCs), checkpoint inhibitors, and multi-specific...

The global microcontroller market is witnessing a significant growth owing to the growth across applications in different segments, such as automotive, communications, energy, consumer devices, and industrial automation and control. Asia-Pacific is contributing significantly to the global microcontroller revenues and its growth during the forecast ...